BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29882921)

  • 21. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes.
    Strathdee G; Appleton K; Illand M; Millan DW; Sargent J; Paul J; Brown R
    Am J Pathol; 2001 Mar; 158(3):1121-7. PubMed ID: 11238060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG island methylation of DNA damage response genes in advanced ovarian cancer.
    Teodoridis JM; Hall J; Marsh S; Kannall HD; Smyth C; Curto J; Siddiqui N; Gabra H; McLeod HL; Strathdee G; Brown R
    Cancer Res; 2005 Oct; 65(19):8961-7. PubMed ID: 16204069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer.
    Eftang LL; Klajic J; Kristensen VN; Tost J; Esbensen QY; Blom GP; Bukholm IR; Bukholm G
    BMC Cancer; 2016 Mar; 16():225. PubMed ID: 26984265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Model of aberrant DNA methylation patterns and its applications in epithelial ovarian cancer.].
    Gu XH; Lu Y; Ma D; Liu XS; Guo SW
    Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):754-9. PubMed ID: 20078962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.
    Liew PL; Huang RL; Weng YC; Fang CL; Hui-Ming Huang T; Lai HC
    Int J Cancer; 2018 Jul; 143(2):355-367. PubMed ID: 29451304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation analysis of tumour suppressor genes in ovarian cancer using MS-MLPA.
    Chmelařová M; Křepinská E; Spaček J; Laco J; Nekvindová J; Palička V
    Folia Biol (Praha); 2012; 58(6):246-50. PubMed ID: 23438850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
    Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
    Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.
    Wiley A; Katsaros D; Chen H; Rigault de la Longrais IA; Beeghly A; Puopolo M; Singal R; Zhang Y; Amoako A; Zelterman D; Yu H
    Cancer; 2006 Jul; 107(2):299-308. PubMed ID: 16773633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and outcomes of patients with BRCA1 or RAD51C methylated versus mutated ovarian carcinoma.
    Bernards SS; Pennington KP; Harrell MI; Agnew KJ; Garcia RL; Norquist BM; Swisher EM
    Gynecol Oncol; 2018 Feb; 148(2):281-285. PubMed ID: 29233532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity.
    Bodelon C; Killian JK; Sampson JN; Anderson WF; Matsuno R; Brinton LA; Lissowska J; Anglesio MS; Bowtell DDL; Doherty JA; Ramus SJ; Talhouk A; Sherman ME; Wentzensen N
    Clin Cancer Res; 2019 Oct; 25(19):5937-5946. PubMed ID: 31142506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of MGMT promoter methylation in endometrial cancer.
    Rimel BJ; Huettner P; Powell MA; Mutch DG; Goodfellow PJ
    Gynecol Oncol; 2009 Jan; 112(1):224-8. PubMed ID: 18973931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression.
    Keita M; Wang ZQ; Pelletier JF; Bachvarova M; Plante M; Gregoire J; Renaud MC; Mes-Masson AM; Paquet ÉR; Bachvarov D
    Gynecol Oncol; 2013 Feb; 128(2):356-63. PubMed ID: 23219462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).
    Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G
    Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
    Castelo-Branco P; Choufani S; Mack S; Gallagher D; Zhang C; Lipman T; Zhukova N; Walker EJ; Martin D; Merino D; Wasserman JD; Elizabeth C; Alon N; Zhang L; Hovestadt V; Kool M; Jones DT; Zadeh G; Croul S; Hawkins C; Hitzler J; Wang JC; Baruchel S; Dirks PB; Malkin D; Pfister S; Taylor MD; Weksberg R; Tabori U
    Lancet Oncol; 2013 May; 14(6):534-42. PubMed ID: 23598174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
    McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
    BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic pathogenesis of human papillomavirus in upper aerodigestive tract cancers.
    Talukdar FR; Ghosh SK; Laskar RS; Kannan R; Choudhury B; Bhowmik A
    Mol Carcinog; 2015 Nov; 54(11):1387-96. PubMed ID: 25213493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
    Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
    Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
    Esteller M; Hamilton SR; Burger PC; Baylin SB; Herman JG
    Cancer Res; 1999 Feb; 59(4):793-7. PubMed ID: 10029064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.